DHT-blocking shampoos occupy a peculiar position in the hair loss product market — marketed heavily, widely available, and the subject of significant consumer confusion about what they can realistically achieve. Understanding the actual mechanism and evidence helps patients spend their money more wisely.
The active ingredients most commonly cited in DHT-blocking shampoos are ketoconazole, caffeine, saw palmetto, and zinc. Of these, ketoconazole has the most evidence — initially developed as an antifungal agent, studies have shown it reduces scalp DHT levels when used regularly and produces modest improvements in hair density in patients with androgenic alopecia. Notably, it is the active ingredient in Nizoral shampoo, which is inexpensive and widely available.
Caffeine shampoo has attracted significant marketing interest following early research showing caffeine penetrates the hair follicle and may stimulate growth in vitro. However, the translation from laboratory findings to meaningful clinical results in humans is not yet clearly established in rigorous trials.
Saw palmetto is a plant extract that inhibits 5-alpha reductase to some degree. The effect is much smaller than prescription finasteride, and the bioavailability through a shampoo — which stays on the scalp for a short time before being rinsed off — limits the practical impact.
The realistic summary is that a ketoconazole shampoo (such as Nizoral) used two to three times per week may provide a modest adjunctive benefit alongside primary treatments like finasteride and minoxidil. It is not a substitute for these treatments and cannot meaningfully slow hair loss on its own.
Related reading
